Miami, FL – March 28, 2019 – Dr. Robin L. Smith is an internationally renowned doctor, business leader, entrepreneur, philanthropist, author, and global thought leader in regenerative medicine. She was recently honored with the International Diplomacy Award from the Regenerative Medicine Foundation (RMF) at the 2019 World Stem Cell Summit (WSCS) for building bridges across sectors of this revolutionary medical field which deals with replacing, engineering or regenerating cells, tissues or organs. Dr. Smith is uniquely positioned to advance the global healthcare industry, creating major advancements in public awareness and medical technologies with her unique biography and passion for preventing and curing disease.
“Dr. Smith is a bridge builder, creating connections and solutions in the fight to improve human health and wellness. She has advanced research, funding and advocacy in regenerative medicine, creating the foundation needed for new cures and the alleviation of human suffering,” said Bernard Siegel, Executive Director of the Regenerative Medicine Foundation and Founder of the annual World Stem Cell Summit. “Robin continues to unite the diverse world of regenerative medicine and stem cell research with her advocacy and leadership. Her talent, energy and action accelerate the field.”
Dr. Smith’s international non-profit Cura Foundation launched the global health movement “Unite To Cure” in April 2018 at the Vatican. The conference built bridges between doctors, health systems, patients, business leaders, regulators, investors, politicians, philanthropists, and leaders of faith to collaborate and speed the development of cures, impact human health and save lives. Pope Francis personally participated in this event, which was moderated by Dr. Sanjay Gupta, Dr. Oz, Meredith Vieira and Dr. Max Gomez; and featured an array of international celebrities, political leaders and patients. Attendees included Dr. Francis Collins, Former Vice President Joe Biden, Katy Perry, Tony Robbins, Deepak Chopra and Peter Gabriel, and more than 300 of the world’s leading doctors, scientists, philanthropists, ministers of health, ethicists and thought leaders from countless industries.
“My goal is to increase awareness for prevention, raise money for new cell therapies and continue to generate dialogue between stakeholders in medicine, research, education and religion. The International Diplomacy Award is meaningful to me because it highlighted my work to bring people together to further our common goals. We must focus on how to treat, prevent and repair damaged tissues and find cures for chronic diseases. We make magic by working together because cell therapy is transformative and will make a major difference to humanity,” said Dr. Smith.
Dr. Smith’s 2020 Fifth International Vatican conference scheduled for May 28th, 29th and 30th, is currently in the works. The conference will build on the huge success of 2018’s “Unite to Cure,” featuring more technology and disruptive innovations with a focus on educating the next generation of healthcare leaders.
The 19th Population Health Colloquium was a hybrid conference and internet event that took place at the Loews Philadelphia Hotel March 18-20, 2018. The Colloquium brought together healthcare providers, payers, pharmaceutical executives, leading technology and solutions companies, and academia and government officials to highlight advances in population health. Among the visionaries in attendance with Robin L. Smith for a special evening dinner program were Meredith Vieira, “Dr. Max” Gomez, Richard M. Cohen and Dr. David Nash building the bridge between Precision Medicine and Population Health while always keeping the patient at the center of the discussion.
One of the new initiatives being launched by the Cura Foundation is Cognitive Warriors. The Mission of Cognitive Warriors is to improve access to quality healthcare for the men and women in the US military suffering from mental health conditions such as depression and PTSD, by helping them to find the resources and technologies that are available to diagnose and treat cognitive disorders. Their goal is to assist 1,000,000 men and women who have served in the U.S. military and reduce suicide rates within this population while helping them to better advocate for themselves and their families.
Dr. Smith received her medical degree from the Yale School of Medicine and an MBA from the Wharton School of Business. She has co-authored two books: Cells Are the New Cure (2017) and The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life (2013).
In 2007, Dr. Smith founded the Stem for Life Foundation (SFLF), devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions. She has served as chairman of the board and president of SFLF since its inception and has been expanding its mission under the Cura brand since 2016. During her tenure as CEO of the NeoStem family of companies from 2006 to 2015, she pioneered the company’s innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization. She raised over $240 million, completing six acquisitions and one divestiture while the company won an array of industry awards.
Dr. Smith has extensive experience serving in executive and board level capacities for various private and public medical enterprises and healthcare-based entities. In 2015, Dr. Smith joined the board of directors of Mynd Analytics (NASDAQ: MYND) as chairman. In 2016, she joined the board of directors of Rockwell Medical (NASDAQ: RMTI) and in 2019 she joined the board of directors of Seelos Therapeutics (NASDAQ:SEEL). She also serves as president and chairman of Stem for Life, Cognitive Warriors, and Cura Foundation, and is vice president and a member of the board of directors of the STOQ Foundation in Rome, Italy. Dr. Smith is co-chairman of the Life Sci advisory board on gender diversity and advisor to Dthera Sciences. She also serves on Sanford Health’s International Board, Alliance for Regenerative Medicine (ARM) Foundation board and the board of overseers at the NYU Langone Medical Center in New York. She previously served on the board of trustees of the NYU Langone Medical Center and is the past chairman of the board of directors for the New York University Hospital for Joint Diseases.
Dr. Smith has recently been named a finalist in the Top Women in Healthcare Awards presented by PR News and Access Intelligence. She will be honored during the Top Women in Healthcare Awards Luncheon on June 5th at the Yale Club in New York City. Along with the International Diplomacy Award from RMF that Dr. Smith was awarded earlier this year, she has also been honored with a 15th Annual Stevie Award for Women in Business, a Business Intelligence Group’s 2018 BIG Award for Business, a Ragan’s PR Daily Award- 2018 Health Care PR & Marketing Award, and a Modern Healthcare and Ad Age Healthcare Marketing IMPACT Award.
Dr. Robin L. Smith is driven to help humanity, find cures and preventions. As a doctor, biotech CEO, nonprofit leader and author, Dr. Smith is singularly positioned to foster collaboration among the stakeholders who can most impact the future of healthcare. She is poised to have a long-lasting and powerful impact on the development of new treatments and the prevention of disease by uniting the international stem cell and regenerative medicine fields.
Company Name: Howard R. Miller Communications
Contact Person: Howard Miller
Email: Send Email
Address:3009 NE Quayside Lane
Country: United States